PB
PharmaCyte Biotech, Inc.
SEC filingBiotechnology · Las Vegas, NV
Amount raised$7Msold at filing
Total offering$7M
Investors in the raise12count reported to the SEC
FiledSep 4, 2025first sale Aug 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Robert M. WeinsteinDirector
Jonathan L. SchechterDirector
Michael M. AbecassisDirector
Carlos N. TrujilloExecutive Officer
Joshua N. SilvermanExecutive Officer, Director
Walker R. WayneDirector
Executive officers, directors and promoters as listed on the Form D.